The Australian Global Health Alliance (Alliance) is deeply concerned about the uncontrolled and accelerating multi-country outbreak of mpox in African countries, centred in the Democratic Republic of Congo (DRC) but spreading rapidly internationally. The Alliance calls on the Australian Government to expedite resources towards mobilisation of an effective, internationally coordinated and equitable response that will […]
MEDIA RELEASE 22 September 2022 Pacific Friends of Global Health welcomes Australia’s commitment of AU$266 million over three years to the Global Fund to Fight AIDS, Tuberculosis and Malaria at its pledging meeting held in New York overnight and hosted by President Biden. It is a welcome contribution to help restore momentum in the fight […]
MEDIA RELEASE 25 April 2022 Pacific Friends of Global Health is calling on the next federal government to urgently invest in the battle to fight malaria in the Pacific and South East Asia, with cases and deaths on the rise. Today marks World Malaria Today and despite years of steady progress, the fight against the […]
Saturday 9 April 2022 End COVID For All and Pacific Friends of Global Health have commended the Australian Government’s pledge of $85 million and at least 10 million COVID vaccine doses to the COVAX Advanced Market Commitment (AMC). At the 2022 Gavi COVAX AMC Summit, held overnight, governments, international organisations, civil society and the private […]
The Commonwealth’s decision to allocate additional funds to global COVID-19 vaccination and broader health efforts has been welcomed by the Pacific Friends of Global Health. However, further commitment will be necessary to meet the urgency of the world’s needs to address the pandemic and restore progress against major infectious diseases such as AIDS, tuberculosis and malaria. Pacific […]
The below document outline a series of recommendations, on behalf of Pacific Friends of Global Health, for the upcoming 2022-23 Federal Budget.
Dear Prime Minister, We write to you out of our grave concern regarding the state of global vaccine inequity, and the opportunity we believe Australia has to help address this vital issue affecting us all….DOWNLOAD PDF OF LETTER
Thursday, December 2, 2021 Australia’s leading epidemiologists, global health, business, development and aid organisations have united to call on the Federal Government to urgently ramp up its global vaccination efforts following the emergence of the Omicron variant. The coalition, brought together by End COVID For All, includes the Business Council of Australia, the Australian Global […]
GENEVA – The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria today unanimously approved a new response mechanism to support countries to respond to COVID-19 and mitigate the impact on programs to fight HIV, TB, malaria and systems for health, effectively doubling the amount of available funding to up to US$1 billion. The […]
06 October 2021 WHO recommendation for wider use of the RTS,S malaria vaccine is largely based on data gathered during malaria vaccine pilots which took place in Kenya, Ghana and Malawi Gavi, the Vaccine Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria and global health agency Unitaid have together committed nearly US$ 70 […]
A REGIONAL COVID RESPONSE NEEDS MORE FROM AUSTRALIA Media Release | 23 September 2021 Pacific Friends of Global Health welcomes the news that the Australian Government has pledged an additional 40 million COVID-19 vaccines for the Indo-Pacific region. Australia has now promised a total of 60 million vaccines by the end of 2022. The announcement […]
GENEVA – The COVID-19 pandemic had a devastating impact on the fight against HIV, TB and malaria in 2020, according to a new report released by the Global Fund today. The Results Report shows that while some progress was made, key programmatic results have declined for the first time in the history of the Global Fund. “To mark […]
Unitaid has invested more than US$ 45 million into hepatitis C since 2015, driving the development of better and more affordable tools and demonstrating that it is possible to reach – and cure – people in resource-limited settings. “We set out to improve hepatitis C care through a complementary set of investments. Over the past […]
Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) announce pricing agreement with pharmaceutical company Hetero Labs LTD to make available generic version of best-in-class second-line therapy for people living with HIV Geneva, 26 July 2021 – Unitaid and CHAI today announced a groundbreaking pricing agreement with pharmaceutical company Hetero Labs LTD to make darunavir boosted […]
